227 related articles for article (PubMed ID: 24890385)
1. An integrated genomic approach identifies persistent tumor suppressive effects of transforming growth factor-β in human breast cancer.
Sato M; Kadota M; Tang B; Yang HH; Yang YA; Shan M; Weng J; Welsh MA; Flanders KC; Nagano Y; Michalowski AM; Clifford RJ; Lee MP; Wakefield LM
Breast Cancer Res; 2014 Jun; 16(3):R57. PubMed ID: 24890385
[TBL] [Abstract][Full Text] [Related]
2. Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis.
Petersen M; Pardali E; van der Horst G; Cheung H; van den Hoogen C; van der Pluijm G; Ten Dijke P
Oncogene; 2010 Mar; 29(9):1351-61. PubMed ID: 20010874
[TBL] [Abstract][Full Text] [Related]
3. CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling.
Kang JM; Park S; Kim SJ; Hong HY; Jeong J; Kim HS; Kim SJ
Oncogene; 2012 Dec; 31(50):5123-31. PubMed ID: 22310290
[TBL] [Abstract][Full Text] [Related]
4. Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity.
Hjelmeland AB; Hjelmeland MD; Shi Q; Hart JL; Bigner DD; Wang XF; Kontos CD; Rich JN
Cancer Res; 2005 Dec; 65(24):11276-81. PubMed ID: 16357132
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2.
Song K; Cornelius SC; Reiss M; Danielpour D
J Biol Chem; 2003 Oct; 278(40):38342-51. PubMed ID: 12876289
[TBL] [Abstract][Full Text] [Related]
6. Differential roles of Smad2 and Smad3 in the regulation of TGF-β1-mediated growth inhibition and cell migration in pancreatic ductal adenocarcinoma cells: control by Rac1.
Ungefroren H; Groth S; Sebens S; Lehnert H; Gieseler F; Fändrich F
Mol Cancer; 2011 May; 10():67. PubMed ID: 21624123
[TBL] [Abstract][Full Text] [Related]
7. Eukaryotic Translation Initiation Factor 4E Is a Feed-Forward Translational Coactivator of Transforming Growth Factor β Early Protransforming Events in Breast Epithelial Cells.
Decarlo L; Mestel C; Barcellos-Hoff MH; Schneider RJ
Mol Cell Biol; 2015 Aug; 35(15):2597-609. PubMed ID: 25986608
[TBL] [Abstract][Full Text] [Related]
8. Smad signaling pathway is a pivotal component of tissue inhibitor of metalloproteinases-3 regulation by transforming growth factor beta in human chondrocytes.
Qureshi HY; Ricci G; Zafarullah M
Biochim Biophys Acta; 2008 Sep; 1783(9):1605-12. PubMed ID: 18471442
[TBL] [Abstract][Full Text] [Related]
9. Histone 3 lysine 9 (H3K9) methyltransferase recruitment to the interleukin-2 (IL-2) promoter is a mechanism of suppression of IL-2 transcription by the transforming growth factor-β-Smad pathway.
Wakabayashi Y; Tamiya T; Takada I; Fukaya T; Sugiyama Y; Inoue N; Kimura A; Morita R; Kashiwagi I; Takimoto T; Nomura M; Yoshimura A
J Biol Chem; 2011 Oct; 286(41):35456-35465. PubMed ID: 21862595
[TBL] [Abstract][Full Text] [Related]
10. Differential role of Sloan-Kettering Institute (Ski) protein in Nodal and transforming growth factor-beta (TGF-β)-induced Smad signaling in prostate cancer cells.
Vo BT; Cody B; Cao Y; Khan SA
Carcinogenesis; 2012 Nov; 33(11):2054-64. PubMed ID: 22843506
[TBL] [Abstract][Full Text] [Related]
11. Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.
Tian F; Byfield SD; Parks WT; Stuelten CH; Nemani D; Zhang YE; Roberts AB
Cancer Res; 2004 Jul; 64(13):4523-30. PubMed ID: 15231662
[TBL] [Abstract][Full Text] [Related]
12. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression.
Ali A; Zhang P; Liangfang Y; Wenshe S; Wang H; Lin X; Dai Y; Feng XH; Moses R; Wang D; Li X; Xiao J
Cell Death Dis; 2015 Mar; 6(3):e1681. PubMed ID: 25766320
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta suppressed Id-1 Expression in a smad3-dependent manner in LoVo cells.
Song H; Guo B; Zhang J; Song C
Anat Rec (Hoboken); 2010 Jan; 293(1):42-7. PubMed ID: 19798702
[TBL] [Abstract][Full Text] [Related]
14. Context-Specific Effects of TGF-β/SMAD3 in Cancer Are Modulated by the Epigenome.
Tufegdzic Vidakovic A; Rueda OM; Vervoort SJ; Sati Batra A; Goldgraben MA; Uribe-Lewis S; Greenwood W; Coffer PJ; Bruna A; Caldas C
Cell Rep; 2015 Dec; 13(11):2480-2490. PubMed ID: 26686634
[TBL] [Abstract][Full Text] [Related]
15. Beta-hydroxybutyrate-induced growth inhibition and collagen production in HK-2 cells are dependent on TGF-beta and Smad3.
Guh JY; Chuang TD; Chen HC; Hung WC; Lai YH; Shin SJ; Chuang LY
Kidney Int; 2003 Dec; 64(6):2041-51. PubMed ID: 14633126
[TBL] [Abstract][Full Text] [Related]
16. Requirement for the SnoN oncoprotein in transforming growth factor beta-induced oncogenic transformation of fibroblast cells.
Zhu Q; Pearson-White S; Luo K
Mol Cell Biol; 2005 Dec; 25(24):10731-44. PubMed ID: 16314499
[TBL] [Abstract][Full Text] [Related]
17. The endogenous ratio of Smad2 and Smad3 influences the cytostatic function of Smad3.
Kim SG; Kim HA; Jong HS; Park JH; Kim NK; Hong SH; Kim TY; Bang YJ
Mol Biol Cell; 2005 Oct; 16(10):4672-83. PubMed ID: 16093355
[TBL] [Abstract][Full Text] [Related]
18. TGF-β transactivates EGFR and facilitates breast cancer migration and invasion through canonical Smad3 and ERK/Sp1 signaling pathways.
Zhao Y; Ma J; Fan Y; Wang Z; Tian R; Ji W; Zhang F; Niu R
Mol Oncol; 2018 Mar; 12(3):305-321. PubMed ID: 29215776
[TBL] [Abstract][Full Text] [Related]
19. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
[TBL] [Abstract][Full Text] [Related]
20. Critical role of Smad2 in tumor suppression and transforming growth factor-beta-induced apoptosis of prostate epithelial cells.
Yang J; Wahdan-Alaswad R; Danielpour D
Cancer Res; 2009 Mar; 69(6):2185-90. PubMed ID: 19276350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
